These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 111323)

  • 1. Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V.
    Jacquillat C; Banzet P; Civatte J; Puissant A; Cottenot F; Israel L; Belaich S; Chastang C; Maral J
    Recent Results Cancer Res; 1978; 68():346-58. PubMed ID: 111323
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant therapy of cutaneous malignant melanoma: a critical review.
    Koh HK; Sober AJ; Harmon DC; Lew RA; Carey RW
    Med Pediatr Oncol; 1985; 13(5):244-60. PubMed ID: 3897817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a nonrandomized trial in malignant melanoma patients (Clark's stages III--V) treated by post-surgical chemoimmunotherapy.
    Serrou B; Pujol H; Domas J; Gauci L
    Recent Results Cancer Res; 1978; 68():363-6. PubMed ID: 752871
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant therapy for malignant melanoma.
    Kaiser LR; Burk MW; Morton DL
    Surg Clin North Am; 1981 Dec; 61(6):1249-57. PubMed ID: 7313933
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials of chemotherapy and chemoimmunotherapy in primary malignant melanoma.
    Jacquillat C; Banzet P; Maral J
    Recent Results Cancer Res; 1982; 80():254-8. PubMed ID: 7036288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma.
    Karakousis CP; Didolkar MS; Han T
    Cancer Treat Rep; 1981; 65(9-10):925-6. PubMed ID: 7273032
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adjuvant chemotherapy of intraocular malignant melanoma. Apropos of 20 cases].
    Sellami M; Weil M; Maral J; Auclerc G; Dhermy P; Aron-Rosa D; Jacquillat C
    J Fr Ophtalmol; 1985; 8(5):423-6. PubMed ID: 3937848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary report of a pilot trial in adjuvant chemotherapy of primary melanoma.
    Kolarić K; Malenica B; Roth A
    Tumori; 1979 Apr; 65(2):229-36. PubMed ID: 462575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
    Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
    N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgical adjuvant therapy for malignant melanoma.
    Pinsky CM; Oettgen HF
    Surg Clin North Am; 1981 Dec; 61(6):1259-66. PubMed ID: 7031933
    [No Abstract]   [Full Text] [Related]  

  • 11. Procarbazine, vinblastine, and actinomycin D in stage III and IV melanoma with or without methanol-extracted residue of Bacillus Calmette-Guérin.
    Kostinas JE; Leone LA; Cuttner J; Vinciguerra V; Green M; De Bellis R; Pajak TF
    Cancer Treat Rep; 1979 Feb; 63(2):197-200. PubMed ID: 376132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.
    Wood WC; Cosimi AB; Carey RW; Kaufman SD
    Surgery; 1978 Jun; 83(6):677-81. PubMed ID: 644461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adjuvant therapy in melanoma management.
    Barth A; Morton DL
    Cancer; 1995 Jan; 75(2 Suppl):726-34. PubMed ID: 7805001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma.
    Porcile G; Musso M; Boccardo F; Rosso R; Santi L
    Tumori; 1979 Apr; 65(2):237-40. PubMed ID: 88784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of imidazole carboxamide and corynebacterium parvum in disseminated melanoma: clinical and immunologic results.
    Clunie GJ; Gough IR; Dury M; Furnival CM; Bolton PM
    Cancer; 1980 Aug; 46(3):475-9. PubMed ID: 6994866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant immunotherapy of malignant melanoma.
    Aranha GV; McKhann CF; Grage TB; Gunnarsson A; Simmons RL
    Cancer; 1979 Apr; 43(4):1297-303. PubMed ID: 445331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.
    Sterchi JM; Wells HB; Case LD; Spurr CL; White DR; Richards F; Muss HB; Jackson DV; Stuart JJ; Cooper MR
    Cancer; 1985 Feb; 55(4):707-12. PubMed ID: 3967167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma.
    Lipton A; Harvey HA; Lawrence B; Gottlieb R; Kukrika M; Dixon R; Graham W; Miller S; Heckard R; Schelzel D; White DS
    Cancer; 1983 Jan; 51(1):57-60. PubMed ID: 6821809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma.
    Robidoux A; Gutterman JU; Bodey GP; Hersh EM
    Cancer; 1982 Jun; 49(11):2246-51. PubMed ID: 7042068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of resectable metastatic melanoma (Stage IVA melanoma).
    Feun LG; Gutterman J; Burgess MA; Hersh EM; Mavligit G; McBride CM; Benjamin RS; Richman SP; Murphy WK; Bodey GP; Brown BW; Mountain CF; Leavens ME; Freireich EJ
    Cancer; 1982 Oct; 50(8):1656-63. PubMed ID: 7116298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.